Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1426
Book Description
A Study of the Antitrust Laws
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1426
Book Description
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 1426
Book Description
The National Banking Review
June 7, 8, 10, 13, 14,15, and 17, 1955. pp.1845-2712
Author: United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 896
Book Description
Committee Serial No. 3. Includes following court cases and documents related to charges of monopoly against petroleum companies. a. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp. Answer of Defendant Socony-Vacuum Oil Co. (p. 839-902). b. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp., Sept. 1, 1953, compilation of documents submitted by Socony-Vacuum Oil Co. Includes documents relating to Iraq Petroleum Co. and New East Development Corp. (p. 903-1054); documents related to Arabian American Oil Co., and Trans-Arabian Pipeline Co. (p. 1055-1228); and documents related to Socony's purchase contracts with Anglo-Iranian Oil Co. and Middle East Pipelines, Ltd. (p. 1229-1521). c. Includes text of agreement between Iran and the National Iranian Oil Co. and the Gulf Oil Co., Socony-Vacuum Oil Co., Standard Oil Co. of New Jersey, Standard Oil Co. of California, Texas Co., Anglo-Iranian Oil Co., de Bataafsche Petroleum Maatschappij, and Compagnie Francaise Petroles (p. 1563-1651). Reviews the current administration of antitrust and anti-monopoly laws.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 896
Book Description
Committee Serial No. 3. Includes following court cases and documents related to charges of monopoly against petroleum companies. a. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp. Answer of Defendant Socony-Vacuum Oil Co. (p. 839-902). b. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp., Sept. 1, 1953, compilation of documents submitted by Socony-Vacuum Oil Co. Includes documents relating to Iraq Petroleum Co. and New East Development Corp. (p. 903-1054); documents related to Arabian American Oil Co., and Trans-Arabian Pipeline Co. (p. 1055-1228); and documents related to Socony's purchase contracts with Anglo-Iranian Oil Co. and Middle East Pipelines, Ltd. (p. 1229-1521). c. Includes text of agreement between Iran and the National Iranian Oil Co. and the Gulf Oil Co., Socony-Vacuum Oil Co., Standard Oil Co. of New Jersey, Standard Oil Co. of California, Texas Co., Anglo-Iranian Oil Co., de Bataafsche Petroleum Maatschappij, and Compagnie Francaise Petroles (p. 1563-1651). Reviews the current administration of antitrust and anti-monopoly laws.
United States Versus Economic Concentration and Monopoly
Author: United States. Congress. House. Select Committee on Small Business
Publisher:
ISBN:
Category : Trusts, Industrial
Languages : en
Pages : 454
Book Description
Publisher:
ISBN:
Category : Trusts, Industrial
Languages : en
Pages : 454
Book Description
Current Antitrust Problems
Author: United States. Congress. House. Committee on the Judiciary. Subcommittee No. 5
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 2846
Book Description
Committee Serial No. 3. Includes following court cases and documents related to charges of monopoly against petroleum companies. a. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp. Answer of Defendant Socony-Vacuum Oil Co. (p. 839-902). b. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp., Sept. 1, 1953, compilation of documents submitted by Socony-Vacuum Oil Co. Includes documents relating to Iraq Petroleum Co. and New East Development Corp. (p. 903-1054); documents related to Arabian American Oil Co., and Trans-Arabian Pipeline Co. (p. 1055-1228); and documents related to Socony's purchase contracts with Anglo-Iranian Oil Co. and Middle East Pipelines, Ltd. (p. 1229-1521). c. Includes text of agreement between Iran and the National Iranian Oil Co. and the Gulf Oil Co., Socony-Vacuum Oil Co., Standard Oil Co. of New Jersey, Standard Oil Co. of California, Texas Co., Anglo-Iranian Oil Co., de Bataafsche Petroleum Maatschappij, and Compagnie Francaise Petroles (p. 1563-1651). Reviews the current administration of antitrust and anti-monopoly laws.
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 2846
Book Description
Committee Serial No. 3. Includes following court cases and documents related to charges of monopoly against petroleum companies. a. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp. Answer of Defendant Socony-Vacuum Oil Co. (p. 839-902). b. U.S. v. Standard Oil Co. of New Jersey, Socony-Vacuum Oil Co., Standard Oil Co. of California, Texas Co., Gulf Oil Corp., Sept. 1, 1953, compilation of documents submitted by Socony-Vacuum Oil Co. Includes documents relating to Iraq Petroleum Co. and New East Development Corp. (p. 903-1054); documents related to Arabian American Oil Co., and Trans-Arabian Pipeline Co. (p. 1055-1228); and documents related to Socony's purchase contracts with Anglo-Iranian Oil Co. and Middle East Pipelines, Ltd. (p. 1229-1521). c. Includes text of agreement between Iran and the National Iranian Oil Co. and the Gulf Oil Co., Socony-Vacuum Oil Co., Standard Oil Co. of New Jersey, Standard Oil Co. of California, Texas Co., Anglo-Iranian Oil Co., de Bataafsche Petroleum Maatschappij, and Compagnie Francaise Petroles (p. 1563-1651). Reviews the current administration of antitrust and anti-monopoly laws.
United States Government Publications Monthly Catalog
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1654
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1654
Book Description
Bowker's Law Books and Serials in Print
GAO Documents
Author: United States. General Accounting Office
Publisher:
ISBN:
Category :
Languages : en
Pages : 828
Book Description
Catalog of reports, decisions and opinions, testimonies and speeches.
Publisher:
ISBN:
Category :
Languages : en
Pages : 828
Book Description
Catalog of reports, decisions and opinions, testimonies and speeches.
Encyclopedia of White-Collar and Corporate Crime
Author: Lawrence M. Salinger
Publisher: SAGE Publications
ISBN: 1452276161
Category : Business & Economics
Languages : en
Pages : 1212
Book Description
Since the first edition of the Encyclopedia of White Collar and Corporate Crime was produced in 2004, the number and severity of these crimes have risen to the level of calamity, so much so that many experts attribute the near-Depression of 2008 to white-collar malfeasance, namely crimes of greed and excess by bankers and financial institutions. Whether the perpetrators were prosecuted or not, white-collar and corporate crime came near to collapsing the U.S. economy. In the 7 years since the first edition was produced we have also seen the largest Ponzi scheme in history (Maddoff), an ecological disaster caused by British Petroleum and its subcontractors (Gulf Oil Spill), and U.S. Defense Department contractors operating like vigilantes in Iraq (Blackwater). White-collar criminals have been busy, and the Second Edition of this encyclopedia captures what has been going on in the news and behind the scenes with new articles and updates to past articles.
Publisher: SAGE Publications
ISBN: 1452276161
Category : Business & Economics
Languages : en
Pages : 1212
Book Description
Since the first edition of the Encyclopedia of White Collar and Corporate Crime was produced in 2004, the number and severity of these crimes have risen to the level of calamity, so much so that many experts attribute the near-Depression of 2008 to white-collar malfeasance, namely crimes of greed and excess by bankers and financial institutions. Whether the perpetrators were prosecuted or not, white-collar and corporate crime came near to collapsing the U.S. economy. In the 7 years since the first edition was produced we have also seen the largest Ponzi scheme in history (Maddoff), an ecological disaster caused by British Petroleum and its subcontractors (Gulf Oil Spill), and U.S. Defense Department contractors operating like vigilantes in Iraq (Blackwater). White-collar criminals have been busy, and the Second Edition of this encyclopedia captures what has been going on in the news and behind the scenes with new articles and updates to past articles.
Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law
Author: Amalia Athanasiadou
Publisher: Kluwer Law International B.V.
ISBN: 9403501146
Category : Law
Languages : en
Pages : 349
Book Description
Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by both United States (US) and European courts and enforcement authorities, and to discuss the applicable legal tests and the main criteria used for their assessment. The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and European Union (EU) competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including: – the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavisand subsequent jurisprudence; – the decision of Lundbeck v. Commissionby the European General Court and the Servier decision of the European Commission; – the Roche/Novartisdecision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU; – an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals, mechanisms affecting generic substitution; – the rejection of the “scope of the patent” test in both the US and the EU and the balancing of patent law and antitrust law considerations in the prevailing applicable tests; – the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law. The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant caselaw, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.
Publisher: Kluwer Law International B.V.
ISBN: 9403501146
Category : Law
Languages : en
Pages : 349
Book Description
Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals and also the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals. This book is one of the first to critically and comparatively analyse how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by both United States (US) and European courts and enforcement authorities, and to discuss the applicable legal tests and the main criteria used for their assessment. The book’s ultimate objective is to provide guidance to the pharmaceutical industry regarding the types of patent settlements, strategies and conduct which may be problematic from US antitrust and European Union (EU) competition law perspectives and to assist practitioners in structuring settlements which are both efficient and compliant. To this end, an exhaustive legal analysis of some of the most controversial issues regarding pharmaceutical patent settlements is provided, including: – the lengthy split among US Circuit Courts on the issue of pay-for-delay settlements, its resolution by the US Supreme Court in FTC v. Actavisand subsequent jurisprudence; – the decision of Lundbeck v. Commissionby the European General Court and the Servier decision of the European Commission; – the Roche/Novartisdecision of the European Court of Justice and the most important decisions by National Competition Authorities on pharma patent settlements in the EU; – an overview of other types of strategies such as product-hopping and product reformulations, no-authorised generic commitments, problematic side-deals, mechanisms affecting generic substitution; – the rejection of the “scope of the patent” test in both the US and the EU and the balancing of patent law and antitrust law considerations in the prevailing applicable tests; – the benefits of settlements and the main criteria for assessing their legitimacy under US antitrust and EU competition law. The analysis provides concrete examples of both illegitimate and legitimate settlements and strategies, emphasising on conduct that falls within a grey zone and on the circumstances and criteria under which such conduct could be deemed problematic from an antitrust perspective. This book will serve as a valuable guide for pharmaceutical companies wishing to minimise the risk of engaging in conduct that could potentially infringe US antitrust and EU competition law. It further aims to save courts and enforcement agencies and also practitioners and academics considerable time and resources by providing an exhaustive analysis of the relevant caselaw, with the ultimate goal to increase legal certainty on the most controversial aspects of patent settlements in the pharmaceutical industry.